CAAP Company: Conavi Medical welcomes Mr. Murray E. Maynard as Chief Executive Officer

June 29, 2016, TORONTO - Conavi Medical Inc, a Toronto-based medical device company that provides image guidance technologies for minimally invasive medical procedures, announced today that Murray Maynard has been appointed the Chief Executive Officer of the company, effective July 4th, 2016.  Mr. Maynard has extensive experience in the cardiovascular device field, including sales, marketing, distribution, manufacturing, finance and board-level roles with several devices companies.  He was most recently the President and CEO of Lifemed Group Inc., a leading Canadian distributor of specialty cardiovascular devices.   Prior to Lifemed, he was involved in the executive management of several medical device companies in Europe, Canada, the USA and the Middle East.

"On behalf of the Board of Directors, we are delighted to have Murray join our team," stated Dr. Brian Courtney.  "Conavi has been successful at developing several platform technologies that address large markets for which there are an abundance of opportunities for clinical impact.  Physicians use intravascular and intracardiac imaging catheters over 750,000 times per year around the world to support several common and emerging minimally invasive procedures.  Murray's skillset and profound familiarity with these markets will be invaluable in leading the company through a period of significant growth."

"Conavi's product pipeline includes some transformational technology that can address sizeable gaps in the current imaging market.  The Conavi portfolio of imaging modalities will provide physicians with significantly enhanced visual guidance to drive better clinical outcomes.  Brian has established a world class team at Conavi and I look forward to working with them in establishing Conavi's technology in all major markets across the globe," stated Mr. Maynard.

Dr. Brian Courtney will remain actively involved as Executive Chairman, while continuing his clinical and research work at Sunnybrook Health Sciences Centre and Sunnybrook Research Institute.

About Conavi Medical Inc.:  Conavi Medical Inc. (formerly Colibri Technologies Inc), is a privately-held Canadian medical device company developing minimally invasive image guidance products, with an initial focus on cardiovascular procedures.  It spun out of research conducted originally at Sunnybrook Research Institute in Toronto, Canada.  The company's first product platform, the ForesightTM Intracardiac Echocardiography System, received FDA 510k clearance in the United States in December 2015.  Conavi previously announced an exclusive distribution agreement in Japan for the Foresight ICE System with Japan Lifeline.  For more information, please visit us at www.conavi.com

For further information: Media Contact: Michelle Macpherson, Director, Sales and Marketing, michelle@conavi.com, 416-482-0100 x 123